Evidence map›Paper›PMID 40255491›Full record

ArticleJB & JS open access

Good Long-Term Clinical Outcome in 50% of Hips With Mild and Moderate Chronic Slipped Capital Femoral Epiphysis Treated With in Situ Fixation: 93 Hips With a Follow-up of 50 Years.

Terje Terjesen, Anders Wensaas

Abstract read
In one paragraph

Article in JB & JS open access. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Terje TerjesenDivision of Orthopaedic Surgery, Oslo University Hospital, Rikshospitalet, and University of Oslo, Oslo, Norway.ORCID https://orcid.org/0000-0003-0252-7941
Anders WensaasDivision of Orthopaedic Surgery, Rikshospitalet, Oslo, Norway.ORCID https://orcid.org/0000-0001-9261-5114

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There is no consensus regarding the initial treatment of slipped capital femoral epiphysis (SCFE). The aim of this study was to analyze the long-term outcome of in situ fixation (ISF) in chronic SCFE. Methods: The study consisted of 79 patients (93 hips), treated with ISF from 1955 to 1993. There were 47 male patients (59%) and 32 female patients with a mean age of 12.8 years (range, 8-16 years) at the time of diagnosis. The mean slip angle was 33.4° (range, 12°-80°). The slip was mild (<30°) in 46 hips (49%), moderate (30°-49°) in 33 (36%), and severe (≥50°) in 14 hips. Long-term clinical outcome was based on the rate of total hip arthroplasty (THA) and the modified Harris Hip Score (mHHS) analyzed by telephone (maximum score 91 points). Results: The mean follow-up time was 51.6 years (range, 30-68 years). Thirty-two hips (34%) had undergone THA at a mean patient age of 55.9 years (range, 21-75 years). The survival rate (percentage of hips that had not undergone THA) was 99% at 20 years of follow-up and fell to 69% (95% confidence interval, 58%-80%) at 50 years. The mean mHHS in 57 of the 61 hips that had not undergone THA was 80.7 points (range, 22-91 points). Good long-term outcome, defined as no THA and mHHS ≥76 points, occurred in 40 of 89 hips (45%). The outcome was worse in hips with severe slips compared with moderate and mild slips (p = 0.020), whereas there was no significant differences between moderate and mild slips (p = 0.817). The only independent risk factor of outcome was high alpha angle. Conclusions: At a mean follow-up of 50 years, the clinical outcome in hips with mild or moderate slipping was good in 50% of the hips, and 27% had been converted to THA. These results are well suited for comparison with future studies of more modern treatment concepts. Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

Identifiers

PMID40255491
PMCPMC12002372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.